Davis Polk advised Crestview Partners, L.P. on the deal. Crestview Partners, L.P. executed its investment in Digicomm Holdings, LLC. Financial terms of the transaction were not...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Morgan Stanley in the offering. Morgan Stanley executed its $1 billion SEC-registered offering of 40,000,000 depositary shares, each representing a 1/1,000th interest in...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Goldman Sachs & Co. LLC and UBS Securities LLC, the representatives of the several underwriters in the offering. LSB Industries, Inc. announced a $187...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Murphy Oil Corporation in the transaction. Murphy Oil annoounced its tender offers for up to $200 million aggregate purchase price of its 5.750% senior...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Terns Pharmaceuticals in the offering, while Davis Polk & Wardwell represented the underwriters. Terns Pharmaceuticals, Inc. (Nasdaq: TERN) has agreed to sell, by...
You must be a Standard 1 Year member to access this content.
Freshfields advised CarLotz on the deal. Davis Polk advised the financial advisers. CarLotz, Inc. (Nasdaq: LOTZ), a leading consignment-to-retail used vehicle marketplace, was sold to Shift...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell advised an affiliate of Elliott Management in the deal. Gibson, Dunn & Crutcher LLP and Legance have acted for RedBird Capital Partner....
You must be a Standard 1 Year member to access this content.
Davis Polk advised Barclays Capital, the manager, in the offering. Arrival executed a SEC-registered at-the-market offering of its ordinary shares for up to an aggregate offering price of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised InSilico Medicine in the transaction. InSilico Medicine completed its $35 million Series D2 financing, bringing the total Series D financing to $95 million....
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sales agent Jefferies in the offering. Vaccitech plc executed an at-the-marketing offering program of its American depositary shares representing its ordinary shares under...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sales agent in the offering. RxSight, Inc. announced its shares of common stock for up to an aggregate amount of $50 million....
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised TransMedics, while Davis Polk advised representatives of the underwriters in the offering. TransMedics Group, Inc. executed its $150 million SEC-registered follow-on offering of...
You must be a Standard 1 Year member to access this content.
